Industry Symposium 13


13:30-15:00   Capital Suite 10-11

The contribution on suppression of activated platelets to hemodialysis therapy

Chair: Claudio Ronco, Vicenza, Italy

Technical review of a novel anti-thrombogenic membrane
Yoshiyuki Ueno, Otsu, Japan
Inhibitory potential of anti-thrombogenic membrane to inflammatory reaction, and how will it contribute to hemodialysis therapy?: Tokai cytokine removal study
Takatoshi Kakuta, Hachioji, Japan
Reducing frequency of hypotension during hemodialysis with anti-thrombogenic membrane in diabetic nephropathy patients: ATHRITE-BP study
Kenji Tsuchida, Tokushima, Japan
Hiroyuki Michiwaki, Tokushima, Japan
Daisuke Hirose, Tokushima, Japan
Jun Minakuchi, Tokushima, Japan
Improvement of platelet count and reduction of heparin dose: TRIATHRON study
Alessandra Brendolan, Vicenza, Italy
Claudio Ronco, Vicenza, Italy

Organised by TORAY

 

back to the timetable